Oxurion NV (EBR: OXUR)
Belgium
· Delayed Price · Currency is EUR
0.230
-0.007 (-2.95%)
Jan 17, 2025, 5:25 PM CET
Oxurion NV Revenue
Oxurion NV had revenue of 1,000.00 EUR in the half year ending June 30, 2024, a decrease of -99.62%. This brings the company's revenue in the last twelve months to 84.00K, down -83.69% year-over-year. In the year 2023, Oxurion NV had annual revenue of 263.00K, down -55.80%.
Revenue (ttm)
84.00K
Revenue Growth
-83.69%
P/S Ratio
n/a
Revenue / Employee
4.20K
Employees
20
Market Cap
836.82K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 263.00K | -332.00K | -55.80% |
Dec 31, 2022 | 595.00K | -533.00K | -47.25% |
Dec 31, 2021 | 1.13M | -950.00K | -45.72% |
Dec 31, 2020 | 2.08M | -1.87M | -47.34% |
Dec 31, 2019 | 3.95M | -1.37M | -25.83% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
argenx SE | 1.71B |
UCB SA | 5.45B |
Fagron NV | 820.76M |
Nyxoah | 5.08M |
Ion Beam Applications | 465.75M |
Onward Medical | -188.00K |
Hyloris Pharmaceuticals | 6.94M |
Sequana Medical NV | 433.50K |